Intaprost Eye Drop contains Bimatoprost 0.03% w/v, a synthetic prostamide analog used primarily for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Bimatoprost acts by increasing the outflow of aqueous humor through both the trabecular meshwork and uveoscleral pathways, thereby effectively lowering IOP and reducing the risk of optic nerve damage and visual field loss. Intaprost Eye Drop is administered topically, typically one drop in the affected eye(s) once daily in the evening. It is contraindicated in patients with hypersensitivity to any component of the formulation. Common adverse effects may include conjunctival hyperemia, eyelash growth, ocular pruritus, and dry eyes. Less frequently, patients may experience blurred vision, eye irritation, or increased pigmentation of the iris and periocular skin. Caution is advised in patients with a history of intraocular inflammation or macular edema. The use of Intaprost Eye Drop should be monitored regularly by an ophthalmologist to assess efficacy and detect potential side effects. Proper administration technique and adherence to prescribed dosing are essential to achieve optimal therapeutic outcomes. This medication should not be used during pregnancy or lactation without medical consultation.